The timing of outcome measurement can define the question a study answers. This trial assessed absorption after treatment had ended, not simply during active administration. Primary trial
Design and findings
Eight people with short-bowel syndrome entered a double-blind randomized crossover comparison of growth hormone plus glutamine against placebo. Their usual diet was maintained. Balance studies five days after the four-week treatment period found no significant improvement in the reported nutrient, fluid, or electrolyte absorption measures. All participants experienced adverse effects. Primary report
Our appraisal: duration of benefit was part of the question
An effect that exists only during exposure and an effect that persists after treatment are different claims. This result should be described with its post-treatment assessment window. It should not be used to invent unmeasured on-treatment benefits or to imply that every possible schedule was tested.
Maintaining the usual diet also matters. Some other approaches combine hormone administration with substantial dietary changes. A different co-intervention means a different treatment package, so apparently conflicting results need design comparison before they can be reconciled.
Balance studies assess the relationship between intake and output under defined conditions. Their interpretation depends on accurate collection, stable intake, and measurement methods. A change in body weight is not a substitute for those absorption measurements.
Crossover designs use each participant as a comparator but still need adequate separation between periods and attention to carryover. Small samples leave uncertainty about modest effects and heterogeneous responses; they do not justify ignoring a consistently negative set of measured outcomes.
This report did not demonstrate the proposed sustained absorption benefit under its tested conditions. Adverse effects belong alongside that negative result. It does not establish a self-treatment approach or a reason to alter nutritional support. Full review should examine washout, balance collection, safety details, and related publications from the same participants.
Frequently asked questions
How many participants were studied?
Eight.
Was the usual diet maintained?
Yes.
Were absorption measurements taken after treatment ended?
Yes, five days later.
Was a significant absorption improvement demonstrated?
No.
Were adverse effects reported?
Yes, in all participants.
Is body-weight change identical to improved absorption?
No.
What timing detail must remain in the conclusion?
The outcome was assessed after treatment withdrawal.